Observational analysis reveals that NCOA4 overexpression enhances ferroptosis sensitivity in prostate cancer, suggesting potential therapeutic implications.
NCOA4 overexpression enhances ferroptosis sensitivity to RSL3 in prostate cancer cells.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: